Edesa Biotech, Inc.
EDSA
$4.72
-$0.01-0.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.41M | -4.22M | -2.25M | -2.23M | -1.75M |
| Total Depreciation and Amortization | 25.60K | 25.90K | 25.50K | 25.90K | 25.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 547.50K | 484.90K | 399.90K | 404.40K | 177.40K |
| Change in Net Operating Assets | 1.75M | 1.69M | -265.00K | 77.10K | -154.50K |
| Cash from Operations | -3.08M | -2.02M | -2.09M | -1.72M | -1.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.50M | 0.00 | 3.50M | 220.50K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -53.10K | -9.00K | -142.40K | -34.00K | 0.00 |
| Cash from Financing | 3.45M | -9.00K | 3.36M | 186.50K | 0.00 |
| Foreign Exchange rate Adjustments | -35.40K | -22.50K | -8.50K | -35.00K | 165.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 328.80K | -2.05M | 1.26M | -1.57M | -1.54M |